AR069511A1 - Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas - Google Patents
Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinasInfo
- Publication number
- AR069511A1 AR069511A1 ARP080105224A ARP080105224A AR069511A1 AR 069511 A1 AR069511 A1 AR 069511A1 AR P080105224 A ARP080105224 A AR P080105224A AR P080105224 A ARP080105224 A AR P080105224A AR 069511 A1 AR069511 A1 AR 069511A1
- Authority
- AR
- Argentina
- Prior art keywords
- recombination
- sequence
- attp
- attr
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Abstract
Secuencias de nucleotidos que son variantes de secuencias de la recombinacion att, implicadas en a recombinacion de ADN con especificidad de secuencia en células eucariotas, donde la recombinacion con especificidad de secuencia se realiza por una integrasa Int del bacteriofago lambda. Estas secuencias de recombinacion son, por ejemplo, attP.b, attP.a, attL.a, attR.a y attR.b. Estas secuencia att permiten una integracion estable del sistema de recombinacion y el direccionamiento de una secuencia de ADN deseada. Se refiere además a un método de recombinacion de ADN con especificidad de secuencia en células eucariotas, que comprende introducir un primer ADN que comprende una secuencia de nucleotidos que contiene al menos una secuencia de recombinacion en una célula, introducir un segundo ADN que comprende una secuencia de nucleotidos que contiene al menos una secuencia de recombinacion adicional en una célula, y realizar la recombinacion con especificidad de secuencia por una integrasa Int del bacteriofago lambda, donde al menos uno de dichos primer o segundo ADN es una secuencia de recombinacion att que es, por ejemplo, attP.b, attP.a, attL.a, attR.a y attR.b. Asimismo se proveen vectores y células que los contienen. Reivindicacion 1: Una molécula de ácido nucleico caracterizada porque es seleccionada entre el grupo consistente attP.b (SEC ID N°:3), attP.a (SEC ID N°:4), attL.a (SEC ID N°:7), attR.a (SEC ID N°:10) y attR.b (SEC ID N°:11) o un derivado u homologo de la misma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07122004 | 2007-11-30 | ||
EP08157764 | 2008-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR069511A1 true AR069511A1 (es) | 2010-01-27 |
Family
ID=40379677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080105224A Pending AR069511A1 (es) | 2007-11-30 | 2008-11-28 | Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas |
Country Status (8)
Country | Link |
---|---|
US (1) | US8404486B2 (es) |
EP (1) | EP2217710A1 (es) |
JP (1) | JP2011504741A (es) |
KR (1) | KR101608225B1 (es) |
AR (1) | AR069511A1 (es) |
CA (1) | CA2706050C (es) |
TW (1) | TW200930815A (es) |
WO (1) | WO2009068645A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012071580A2 (en) * | 2010-11-25 | 2012-05-31 | Applied Stemcell, Inc. | Enhanced gene expression |
US11078493B2 (en) * | 2016-06-21 | 2021-08-03 | Nanyang Technological University | Site-specific DNA recombination |
WO2019030373A1 (en) * | 2017-08-11 | 2019-02-14 | Boehringer Ingelheim International Gmbh | INTEGRATION SITES IN CHO CELLS |
WO2023201243A1 (en) * | 2022-04-13 | 2023-10-19 | Baylor College Of Medicine | Bacterial biosensors for diagnosing and treating inflammation |
CN117430696A (zh) * | 2022-07-22 | 2024-01-23 | 北京智仁美博生物科技有限公司 | 用于表达Fab片段库的重组系统 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0937098T3 (da) | 1995-06-07 | 2002-12-02 | Invitrogen Corp | Rekombinatorisk kloning under anvendelse af gensplejsede rekombinationssites |
EP2336148A1 (en) * | 1999-03-02 | 2011-06-22 | Life Technologies Corporation | Compositions and methods for use in recombinational cloning of nucleic acids |
DE19941186A1 (de) * | 1999-08-30 | 2001-03-01 | Peter Droege | Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen |
WO2005017170A2 (en) | 2002-06-04 | 2005-02-24 | Michele Calos | Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
TW200502390A (en) | 2002-11-28 | 2005-01-16 | Peter Droege | Sequence specific DNA recombination in eukaryotic cells |
JP2004248509A (ja) * | 2002-11-29 | 2004-09-09 | Boehringer Ingelheim Pharma Gmbh & Co Kg | 真核細胞内における配列特異的dna組換え |
-
2008
- 2008-11-28 JP JP2010535395A patent/JP2011504741A/ja active Pending
- 2008-11-28 US US12/744,754 patent/US8404486B2/en active Active
- 2008-11-28 AR ARP080105224A patent/AR069511A1/es active Pending
- 2008-11-28 EP EP08854278A patent/EP2217710A1/en not_active Ceased
- 2008-11-28 WO PCT/EP2008/066430 patent/WO2009068645A1/en active Application Filing
- 2008-11-28 TW TW097146490A patent/TW200930815A/zh unknown
- 2008-11-28 CA CA2706050A patent/CA2706050C/en active Active
- 2008-11-28 KR KR1020107011795A patent/KR101608225B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US20110189729A1 (en) | 2011-08-04 |
JP2011504741A (ja) | 2011-02-17 |
CA2706050A1 (en) | 2009-06-04 |
TW200930815A (en) | 2009-07-16 |
KR20100097123A (ko) | 2010-09-02 |
KR101608225B1 (ko) | 2016-04-01 |
CA2706050C (en) | 2019-01-22 |
EP2217710A1 (en) | 2010-08-18 |
US8404486B2 (en) | 2013-03-26 |
WO2009068645A1 (en) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11118224B2 (en) | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs | |
JP2023082141A (ja) | CasZ組成物及び使用方法 | |
FI3250691T3 (fi) | Crispr hybridi dna/rna polynukleotidit ja käyttömenetelmät | |
JP7429642B2 (ja) | 非天然塩基対組成物および使用の方法 | |
CN114207129A (zh) | 用于在半合成生物体中复制、转录和翻译的试剂和方法 | |
MX346862B (es) | Secuencias consenso de envoltura de vih y método para usar las mismas. | |
FI3597749T3 (fi) | Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten | |
ES2687468T3 (es) | Método de amplificación de ADN basado en invasión de cadena | |
CN108368503A (zh) | 用于受控dna片段化的方法 | |
AR069511A1 (es) | Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas | |
WO2021041267A1 (en) | Enzymatic rna capping method | |
EP4450642A3 (en) | Single molecule nucleic acid sequence analysis processes and compositions | |
ES2506466T3 (es) | Plásmido auto-supresor | |
CO2020015707A2 (es) | Casetes de expresión de α-glucosidasa de ácido optimizado con codón y métodos de uso del mismo | |
BR112019017657A2 (pt) | método para replicação ou amplificação de dna circular | |
ES2383716T3 (es) | Composiciones y métodos que utilizan ARN de interferencia de un gen del tipo OPR3 para el control de nemátodos | |
AR101779A2 (es) | Secuencias de nucleótidos msca1 que afectan la fertilidad vegetal masculina y método para usar las mismas | |
TW202128994A (zh) | 真核半合成生物 | |
AR065282A1 (es) | Composiciones y metodos que utilizan arn de transferencia de genes tipo cad para el control de nematodos | |
MX2021008867A (es) | Composiciones reactantes marcadas de intensidad alta y metodos de secuenciamiento. | |
ES2525707T3 (es) | Uso de microRNAs para el control de ácidos nucleicos colaboradores de virus | |
US20230086782A1 (en) | Base editor lacking hnh and use thereof | |
AU2020336278A1 (en) | Enzymatic RNA capping method | |
JP2019501652A5 (es) | ||
US12012432B2 (en) | Nucleic acid complex, method for forming nucleic acid hybridization, pharmaceutical composition, nucleic acid probe, and complementary-strand nucleic acid complex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |